- Chicoutimi
- http://123.57.146.97:3000/shannanrosenst
-
In a phase 2 study, the medication showed up to 20% average weight loss at 52 weeks for people with obesity or overweight without diabetes and 17% for those with overweight/obesity and type 2 diabetes.
- Joined on
2026-04-01
Block a user
There are no packages yet.
For more information on the package registry, see the documentation.